Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma.
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2010
At a glance
- Drugs IMC GP75 (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 28 Oct 2008 Actual patient number (31) added as reported by ClinicalTrials.gov.
- 28 Oct 2008 Actual end date (Sep 2004) added as reported by ClinicalTrials.gov.
- 05 Sep 2007 Status changed from in progress to completed.